Feb 7, 2024 Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference Learn More
Jan 30, 2024 Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study Learn More
Jan 25, 2024 Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million Learn More
Jan 22, 2024 Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient Learn More